00:11:38 Vickie Danaher In addition to switches, we want to watch for patients combining oral and injectable GLP-1 agonists
Most patients can continue their usual dose, but TSH monitoring during the first 3 to 6 months of tirzepatide is reasonable
Shared decision-making to address the needs and preferences of each patient, and the individual characteristics that influence the risks and benefits of therapy for each patient are an important consideration [58]
An operator that communicates clearly about wagering terms, jackpots, and tournament schedules usually earns repeat visits, because it turns every session into a predictable, enjoyable routine rather than a guessing game
Anything less than that, and you are stacking active drug on top of active drug in a way your body was never meant to handle
Side effects to expect during the transition Because your body has already adapted to GLP-1 receptor stimulation from tirzepatide, the transition to semaglutide is generally well tolerated